• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995 - 2004年美国丙型肝炎相关死亡率的变化趋势

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

作者信息

Wise Matthew, Bialek Stephanie, Finelli Lyn, Bell Beth P, Sorvillo Frank

机构信息

Department of Epidemiology, School of Public Health, University of California, Los Angeles, CA 90095-1772, USA.

出版信息

Hepatology. 2008 Apr;47(4):1128-35. doi: 10.1002/hep.22165.

DOI:10.1002/hep.22165
PMID:18318441
Abstract

UNLABELLED

The disease burden and mortality from hepatitis C are predicted to increase in the United States as the number of persons with long-standing chronic infection grows. We analyzed hepatitis C mortality rates derived from US Census and multiple-cause-of-death data for 1995-2004. Deaths were considered hepatitis C-related if: (1) hepatitis C was the underlying cause of death, (2) chronic liver disease was the underlying cause and hepatitis C was a contributing cause, or (3) human immunodeficiency virus was the underlying cause and chronic liver disease and hepatitis C were contributing causes. A total of 56,409 hepatitis C-related deaths were identified. Mortality rates increased 123% during the study period (1.09 per 100,000 persons to 2.44 per 100,000), but average annual increases were smaller during 2000-2004 than 1995-1999. After peaking in 2002 (2.57 per 100,000), overall rates declined slightly, but continued to increase among persons aged 55-64 years. Overall increases were greater among males (144%) than females (81%) and among non-Hispanic blacks (170%) and Native Americans (241%) compared to non-Hispanic whites (124%) and Hispanics (84%). The 7,427 hepatitis C deaths in 2004 (mean age: 55 years), corresponded to 148,611 years of potential life lost. The highest mortality rates in 2004 were observed among males, persons aged 45-54 and 55-64 years, Hispanics, non-Hispanic blacks, and non-Hispanic Native American/Alaska Natives.

CONCLUSION

Overall, hepatitis C mortality has increased substantially since 1995. Despite small declines in recent years, rates have continued to increase among persons aged 55-64 years. Hepatitis C is an important cause of premature mortality.

摘要

未标注

随着长期慢性感染丙型肝炎病毒的人数增加,预计美国丙型肝炎的疾病负担和死亡率将会上升。我们分析了1995 - 2004年美国人口普查数据以及多死因数据中的丙型肝炎死亡率。若符合以下情况,则死亡被视为与丙型肝炎相关:(1)丙型肝炎是根本死因;(2)慢性肝病是根本死因且丙型肝炎是促成死因;或(3)人类免疫缺陷病毒是根本死因且慢性肝病和丙型肝炎是促成死因。共确定了56409例与丙型肝炎相关的死亡病例。在研究期间,死亡率上升了123%(从每10万人1.09例升至每10万人2.44例),但2000 - 2004年期间的年均增长率低于1995 - 1999年。在2002年达到峰值(每10万人2.57例)后,总体死亡率略有下降,但在55 - 64岁人群中继续上升。总体而言,男性(144%)的死亡率增长幅度大于女性(81%),非西班牙裔黑人(170%)和美国原住民(241%)的死亡率增长幅度大于非西班牙裔白人(124%)和西班牙裔(84%)。2004年有7427例丙型肝炎死亡病例(平均年龄:55岁),相当于148611年的潜在寿命损失。2004年死亡率最高的人群为男性、45 - 54岁和55 - 64岁人群、西班牙裔、非西班牙裔黑人以及非西班牙裔美国原住民/阿拉斯加原住民。

结论

总体而言,自1995年以来丙型肝炎死亡率大幅上升。尽管近年来略有下降,但55 - 64岁人群的死亡率仍在继续上升。丙型肝炎是过早死亡的一个重要原因。

相似文献

1
Changing trends in hepatitis C-related mortality in the United States, 1995-2004.1995 - 2004年美国丙型肝炎相关死亡率的变化趋势
Hepatology. 2008 Apr;47(4):1128-35. doi: 10.1002/hep.22165.
2
Chronic liver disease mortality in the United States, 1990-1998.1990 - 1998年美国慢性肝病死亡率
Hepatology. 2004 Feb;39(2):476-83. doi: 10.1002/hep.20049.
3
Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis.美国男性和女性中酒精与丙型肝炎死亡率:生命表分析
Alcohol Clin Exp Res. 2007 Feb;31(2):285-92. doi: 10.1111/j.1530-0277.2006.00304.x.
4
Sexual and reproductive health of persons aged 10-24 years - United States, 2002-2007.2002 - 2007年美国10 - 24岁人群的性与生殖健康
MMWR Surveill Summ. 2009 Jul 17;58(6):1-58.
5
Surveillance for acute viral hepatitis - United States, 2007.2007年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2009 May 22;58(3):1-27.
6
A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001.1990 - 2001年美国哮喘死亡率的多死因分析
J Asthma. 2005 Nov;42(9):757-63. doi: 10.1080/02770900500308189.
7
The effect of revised populations on mortality statistics for the United States, 2000.2000年美国人口修订对死亡率统计数据的影响。
Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24.
8
Deaths: final data for 1996.死亡情况:1996年最终数据。
Natl Vital Stat Rep. 1998 Nov 10;47(9):1-100.
9
Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.美国艾滋病病毒感染对甲型血友病患者年龄及死因的影响。
Am J Hematol. 2001 Apr;66(4):229-40. doi: 10.1002/ajh.1050.
10
Surveillance for violent deaths--National Violent Death Reporting System, 16 states, 2005.暴力死亡监测——国家暴力死亡报告系统,16个州,2005年
MMWR Surveill Summ. 2008 Apr 11;57(3):1-45.

引用本文的文献

1
Quantifying years of life lost in Australia: a multiple cause of death analysis.量化澳大利亚的寿命损失年数:多死因分析
Int J Epidemiol. 2024 Dec 16;54(1). doi: 10.1093/ije/dyae177.
2
HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study.2004年至2021年中国重庆丙型肝炎患者丙型肝炎病毒RNA阳性情况:一项横断面研究
BMC Infect Dis. 2024 Nov 4;24(1):1236. doi: 10.1186/s12879-024-09978-7.
3
Sustained virological response in chronic hepatitis C patients by direct-acting antiviral treatment significantly reduces liver stiffness over 24 weeks posttreatment.
直接作用抗病毒治疗可使慢性丙型肝炎患者获得持续病毒学应答,显著降低治疗后 24 周时的肝硬度。
Medicine (Baltimore). 2024 May 10;103(19):e38096. doi: 10.1097/MD.0000000000038096.
4
Hepatitis C (HCV) among Black and Latino sexual minority men (SMM) in the Southern United States: Protocol of a prospective cohort epidemiological study.美国南部黑人及拉丁裔男同性恋者中的丙型肝炎(HCV):一项前瞻性队列流行病学研究方案。
PLoS One. 2023 Jul 6;18(7):e0288129. doi: 10.1371/journal.pone.0288129. eCollection 2023.
5
Effectiveness of Sofosbuvir and Daclatasvir in treatment of Hepatitis-C: An experience of tertiary care hospital in Karachi.索磷布韦和达卡他韦治疗丙型肝炎的有效性:卡拉奇一家三级医院的经验
Pak J Med Sci. 2021 Nov-Dec;37(7):2014-2019. doi: 10.12669/pjms.37.7.4627.
6
Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.按病因和后遗症划分的肝脏相关死亡率变化:根本死因与多种死因。
Popul Health Metr. 2021 Apr 29;19(1):22. doi: 10.1186/s12963-021-00249-0.
7
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study.代偿期肝硬化合并慢性丙型肝炎和酒精性肝病患者腹水和外周血淋巴细胞亚群特征:一项关键性研究。
Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420929587. doi: 10.1177/2058738420929587.
8
Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt.描述埃及丙型肝炎病毒传播中肠外驱虫治疗的历史作用。
Int J Epidemiol. 2020 Jun 1;49(3):798-809. doi: 10.1093/ije/dyaa052.
9
Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives.一项回顾性研究表明,美国印第安人/阿拉斯加原住民接受直接抗病毒药物治疗后持续病毒学应答率很高。
Open Forum Infect Dis. 2019 Jul 4;6(7):ofz128. doi: 10.1093/ofid/ofz128. eCollection 2019 Jul.
10
Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience.索磷布韦联合利巴韦林治疗丙型肝炎基因3型肝硬化患者的安全性和有效性:一项真实世界研究
Cureus. 2019 Feb 4;11(2):e4012. doi: 10.7759/cureus.4012.